osimertinib adjuvant therapy in patients with early stage egfr mutated nsclc after tumour resection
Published 3 years ago • 55 plays • Length 6:30Download video MP4
Download video MP3
Similar videos
-
2:33
adaura: osimertinib adjuvant therapy in egfr mutated nsclc
-
2:12
esmo 2020 highlights on adjuvant osimertinib for egfr mutated nsclc: the adaura study
-
1:46
osimertinib after surgery significantly improves survival in resected egfr-mutated nsclc
-
59:19
precision oncology in early-stage lung cancer, with adjuvant egfr-targeted therapy leading the way
-
5:03
adaura results: adjuvant osimertinib for egfrm non-small cell lung cancer
-
3:52
is adjuvant chemotherapy in egfr mutated nsclc still required?
-
6:20
asco 2023 highlights on adjuvant osimertinib in resected egfr mutated nsclc: the adaura trial
-
2:21
osimertinib ipilimumab in egfr-mutated nsclc
-
3:30
adaura: osimertinib adjuvant therapy on cns disease recurrence
-
3:31
osimertinib plus gefitinib for treatment of egfr-mutated non-small cell lung cancer
-
10:33
dr ajay yadav osimertinib as adjuvant therapy in patients with resected egfrm stage in iia nsclc up
-
8:06
adaura: osimertinib post-tumor resection in nsclc
-
10:45
debate: adjuvant egfr-directed therapy for patients with early stage nsclc? - no
-
11:18
dr anup toshniwal osimertinib as adjuvant therapy in patients with resected egfrm stage ib iiia nscl
-
2:28
amivantamab in patients with egfr ex20ins-mutated nsclc
-
10:20
role of adjuvant osimertinib in early stage nsclc
-
3:19
adjuvant osimertinib in resected egfr-mutated nsclc
-
50:38
adjuvant egfr tki therapy in patients with completely resected non-small-cell lung cancer: curren...
-
2:20
adjuvant osimertinib in resected egfrm nsclc: the os data from the adaura trial